As of 2024-12-14, the EV/EBITDA ratio of Amryt Pharma Holdings Ltd (AMYT.L) is -27.73. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AMYT.L's latest enterprise value is 514.53 mil GBP. AMYT.L's TTM EBITDA according to its financial statements is -18.55 mil GBP. Dividing these 2 quantities gives us the above AMYT.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 3.9x - 11.0x | 7.4x |
| Forward P/E multiples | 5.3x - 9.0x | 7.0x |
| Fair Price | (43.96) - (60.80) | (52.70) |
| Upside | -130.7% - -142.5% | -136.9% |
| Date | EV/EBITDA |